Oxycodone

Among the most commonly monitored opioids in pain management and drugs of abuse testing programs, oxycodone is a Schedule II semisynthetic opioid derived from thebaine. Laboratory testing applications include pain management compliance monitoring, drugs of abuse screening, forensic toxicology investigations, postmortem toxicology, workplace drug testing, and clinical toxicology assessments in emergency departments evaluating suspected opioid overdose, with detection of both oxycodone and its metabolite oxymorphone helping to confirm active use. UTAK’s Pain Management and DAU panels contain oxycodone in lyophilized urine and whole blood matrices at multiple concentration levels, supporting both immunoassay screening and confirmation methods used in clinical and forensic laboratories. Stock and custom QC solutions can incorporate oxymorphone and related opioids such as hydrocodone, hydromorphone, morphine, codeine, fentanyl, methadone, buprenorphine, and other commonly monitored analytes to address your laboratory’s comprehensive pain management and drugs of abuse testing requirements.